Investigational New Drugs Oerlemans, R, Berkers, C R, Assaraf, Y G, Scheffer, G L, Peters, G J, Verbrugge, S E, Cloos, J, Slootstra, J, Meloen, R H, Shoemaker, R H, Dijkmans, B A C, Scheper, R J, Ovaa, H & Jansen, G 2018, ' Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide ', Investigational New Drugs, vol. 36, no. 5, pp. 797-809 . https://doi.org/10.1007/s10637-018-0569-x Investigational New Drugs, 36(5), 797-809. Kluwer Academic Publishers Investigational New Drugs, 36(5), 797-809
Journal for Immunotherapy of Cancer, 9(3):e001962. BioMed Central Koster, B D, López González, M, van den Hout, M F, Turksma, A W, Sluijter, B J, Molenkamp, B G, van Leeuwen, P A, Vosslamber, S, Scheper, R J, van den Eertwegh, A J, van den Tol, M P, Jordanova, E J & de Gruijl, T D 2021, ' T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment ', Journal for Immunotherapy of Cancer, vol. 9, no. 3, e001962 . https://doi.org/10.1136/jitc-2020-001962 Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)